routine preoperative psychiatric assessment for STN DBS surgery and were assessed for lifetime and current psychiatric diagnoses. The catchment area for referrals consisted primarily of the province of Ontario; four patients were referred from outside the province. Patients were consecutive referrals for neurosurgical assessment between September 2002 and March 2004. Although these patients retained a good motor response to dopaminergic medications, their responses were complicated by refractory disabling motor fluctuations and dyskinesias. When initially considered as candidates for DBS, patients had been prescreened by their referring neurologists (primarily movement disorder neurologists) to rule out overt dementia or active disabling psychiatric symptoms. Patients did not routinely undergo psychiatric assessment prior to referral for consideration of surgery. The prescreened patients were referred to our movement disorders neurologist (E.M.) subspecializing in neurosurgical patients and were then referred for neuropsychiatric and neuropsychological assessment if they were reasonable surgical candidates fulfilling CAPSIT-PD criteria and were interested in, and able to tolerate, surgery. The cohort included patients with potentially treatable psychiatric symptoms (identified by E.M.) who were otherwise good surgical candidates.
The characteristics of the patients are presented in Table  1 . Four of 40 patients were excluded from surgery based on impaired cognitive status; otherwise, all patients fulfilled cognitive criteria as per the CAPSIT-PD protocol. 4 One patient was excluded from surgery because of an advanced age (Ͼ 70 years).
Levodopa equivalents were estimated as follows: total levodopa equivalents = regular levodopa dose ϫ 1 ϩ levodopa continuous release dose ϫ 0.75 ϩ pramipexole dose ϫ 67 ϩ ropinorole dose ϫ 16.67 ϩ pergolide dose ϫ 100 ϩ bromocriptine dose ϫ 10 ϩ (regular levodopa dose ϩ [levodopa continuous release dose ϫ 0.75]) ϫ 0.25 if taking tolcapone. 8 
Patient Evaluation
Patients were evaluated using the MINI, a semistructured diagnostic interview based on the DSM-IV criteria, which elicits selected previous and current Axis I psychiatric disorders. 17 The MINI is a shortened version of the semistructured diagnostic interview, the Structured Clinical Interview for DSM-IV. 18 All symptoms were confirmed on a psychiatric interview conducted by the same psychiatrist, and corroborative collateral and caregiver information were obtained when available. In screening for comorbid disorders, we used a nonhierchical approach to diagnosis; that is, a diagnosis was rendered if the patient fulfilled criteria for the disorder. The severity of past episodes was qualitatively assessed according to the duration of symptoms, need for intervention (change in medications, psychotropic medications, psychiatric assessment, suicidal or behavioral issues, and hospitalization), and response to intervention. Patients were assessed while on medications. The duration of each assessment was approximately 1 to 2 hours.
Current mood and anxiety disorders were diagnosed using the MINI. The severity of current depression was evaluated with the clinician-rated MADRS and the patient-rated BDI, whose psychometric properties have been investigated in patients with PD. 12, 13 Psychotic symptoms were specifically screened and reported as delusions, hallucinations (visual or auditory), or minor hallucinations (for example, shadows, presence hallucinations, and illusions). 5 Dopamine dysregulation syndrome characterized by levodopa abuse, novelty-seeking behaviors, and secondary hypomania was specifically evaluated. 7 Levodopa abuse was determined using the MINI. Dopaminergic medication was added to the screening list of nonalcoholic psychoactive substance use disorders. Behaviors including pathological gambling were also screened.
To decrease the possibility of underreporting due to a patient's concerns regarding their psychiatric status, which could affect the assessment of surgical candidacy, to optimize the treating team's ability to identify and actively manage any underlying symptoms, and to identify patients requiring active postoperative follow up, patients were instructed to be as frank as possible.
Results
Patient characteristics are reported in Table 1 . Six patients (15%) had a total of three Axis I diagnoses, nine patients (23%) had two, and 16 patients (40%) had one. Thirty-one (78%) of 40 patients had at least one lifetime or current Axis I diagnosis. The results of the diagnostic assessments along with reported rates of psychiatric disorders in the literature on PD in general are presented in Table 2 .
Fifteen (38%) of 40 patients were considered to have an elevated risk of psychiatric disorder. Diagnoses among these patients included a history of medication-induced mania with psychosis (three patients), current depression contraindicating surgery (MADRS Ͼ 19; six patients), current active delusional symptoms (one patient), levodopa abuse (one patient), pathological gambling (one patient); clinically severe panic disorder unrelated to motor fluctuations (two patients), and a history of complicated depression (one patient). Twelve (30%) of 40 patients were relatively contraindicated for surgery pending psychiatric treatment because of, and per the CAPSIT-PD criteria, active depressive (MADRS Ͼ 19), manic, or delusional symptoms; uncontrolled levodopa abuse; pathological gambling; or severe panic symptoms. Three of these 12 patients were excluded from STN stimulation surgery because of cognitive impairment.
The mean rating scale scores of the depressed (DSM-IV diagnosis) compared with the nondepressed groups are reported in Table 3 . The mean clinician-rated MADRS score (t = 5.96, df = 36, p Ͻ 0.0001) and the patient-rated BDI score (t = 3.23, df = 36, p = 0.0026) were statistically significant between the depressed and nondepressed groups. Note that on an individual level, however, two patients who were relatively contraindicated for surgery because they demonstrated moderately severe depression (MADRS Ͼ 19) scored only a 5 on the BDI (BDI Ͻ 10: no depression).
Twelve patients either required treatment before surgery or were considered to have an elevated risk of psychiatric disorder given their history. Following treatment for panic disorder, one patient has since been able to tolerate further dopaminergic medications, no longer requiring neurosurgical intervention. Of the remaining 11 patients, eight have since undergone surgery and a postoperative follow up of at least 3 months. The other three patients have either recently undergone or will undergo surgery. The mean duration of time since surgery is 16 months (standard deviation 6.4 months). Patients continued to receive their antidepressants, atypical neuroleptics, mood stabilizers, and benzodiazepines throughout surgery and the postoperative period.
Postoperative psychiatric outcomes in the eight patients who have undergone surgery were as follows. Of three patients with a preoperative history of mania and psychosis, one patient experienced transient stimulation-linked right STN voltage-dependent manic symptoms within the first 2 postoperative months, which resolved with a decrease in voltage; the second patient suffered dopaminergic withdrawal symptoms together with transient postoperative depression fulfilling diagnostic criteria within the first 2 postoperative months, which resolved with increases in dopaminergic medications; and the third patient died for reasons unrelated to his psychiatric status. One patient with preoperative depression had transient depression associated with psychosocial factors within the 1st postoperative year; the depression was resolved with an increase in dopaminergic medications and antidepressants. Another patient with preoperative depression experienced a surgical complication of frontal hemorrhage with good recovery and no psychiatric complications. One patient with preoperative severe depression, diagnosed according to patient-rated scales and a history of attempted suicide, had mild, transient intraoperative delusional symptoms but otherwise had an unremarkable psychiatric course. A fourth patient with preoperative depression had an unremarkable course. The final patient with a preoperative history of a complicated depression and history of an attempted suicide suffered postoperative anxiety symptoms during the first 3 postoperative months.
Discussion
In the present investigation 40 consecutive patients with advanced PD who had been referred to our service as part of the routine preoperative psychiatric assessment for STN DBS surgery were assessed for lifetime and current psychiatric diagnoses. As part of the selection process for surgical candidacy, the study population would routinely have been prescreened by referring neurologists for the absence of dementia or active disabling psychiatric symptomatology. Our results highlight the high psychiatric burden in this popula- tion with advanced PD even when prescreening excluded patients who would be considered poor surgical candidates because of severe psychiatric dysfunction, dementia, or other factors. The number of patients who were not referred for surgical assessment for these reasons during prescreening was not known. Many of the psychiatric symptoms reported among patients with PD are more common in those with dementia; therefore, one would expect the rates of psychiatric illness in patients in this study to be lower than those in the general PD population. The rates of psychiatric illness in our sample are greater than expected. The psychiatric assessment and semistructured diagnostic interview were performed by a single nonblinded interviewer, which may have also contributed to bias. As reflected in the wide CIs, our sample size was small, which may have also contributed to bias. Note, however, that the sample size is consistent with those in the literature on STN stimulation. Because this study lacked a control group, we compared psychiatric disorder rates with those reported in the general literature on PD. Nevertheless, the population of potential surgical candidates being studied may have had a higher rate of psychiatric symptoms than other previously studied subsets of the PD population given the long duration and severity of their illness. Similarly, the psychological impact of the fear of deterioration, uncertainty, or expectation of surgery may have also played a role in the expression of depression or anxiety symptoms. Despite these general considerations, we believe that the study sample reflects the clinical reality of neurosurgical referrals prior to careful neuropsychological or neuropsychiatric assessment. Certainly, this reality may differ from that at other surgical centers, depending on the extent of initial systematic psychiatric screening that occurs prior to any referral for surgical consideration. Note that this study differs from other previously reported ones in that either the psychiatric assessment is not described or patients with active psychiatric disorders are excluded from outcome analyses.
A statistically significant difference was noted in the clinician-rated MADRS and patient-rated BDI scores between depressed (DSM-IV diagnosis) and nondepressed patients. Two patients, however, with diagnoses of moderately severe depression (MADRS Ͼ 19) had very low scores (that is, 5) on the patient-rated BDI. The limitations in the reliability of this latter scale were reflected in the extended CIs and may be a result of limited insight into, or denial of, psychiatric symptoms or their minimization because of concerns regarding surgical eligibility. This finding raises the question of the reliability of patient-rated depression rating scales as the sole instrument for assessing depression.
The prevalence of medication-induced mania in our study may be elevated in comparison to that in the general PD population given the context of a cohort having advanced PD with an onset at a relatively young age together with the use of multiple medications and high levodopa dosage equivalents. The prevalences of depression, medication-induced psychotic symptoms, and anxiety disorders were either similar to, or greater than, those in the general PD population.
In the present study at least one previous or current Axis I psychiatric disorder was diagnosed in 78% of patients; at least three separate disorders were diagnosed in 15%. Notably, the Axis I diagnoses do not capture the full range of symptoms reported in the PD literature including the extent of psychotic symptoms, apathy, hypersexuality, and mood fluctuations.
Surgery was relatively contraindicated in 12 (30%) of 40 patients, pending psychiatric treatment because of active depressive (MADRS Ͼ 19), manic, or delusional symptoms; uncontrolled levodopa abuse; pathological gambling; or severe panic symptoms. Determination of a psychiatric risk was based on the CAPSIT-PD criteria, previous reports of postoperative exacerbation in patients with these symptoms, 4, 9 or the likelihood of difficulties in tolerating the surgical procedure given the severity of active symptoms on presentation. Whether patients with medicationinduced symptoms (for example, pathological gambling, mania, or hallucinations) might improve following surgery has not yet been determined. Whether the cutoff for the CAPSIT-PD criteria is appropriate is not known. Authors of two previous studies on the role of preoperative depression in postoperative depression outcomes had contradictory conclusions. 2, 9 Data in recent literature indicate that the CAPSIT-PD criteria contraindicating surgery in patients with moderate depression is overly stringent. 6 For instance, in one study, patients with moderately severe depression at the time of surgery did not have elevated depression rating scores at the 1st postoperative year follow up. Three years after surgery, 14% of these patients had worsened depression scores and 86% had improved scores. In contrast, 50% of patients with severe depression at the time of surgery had severe depression 3 years after surgery. 6 Note, however, that the authors of this study did not report the premorbid history of depression or use of antidepressants, which may play a role in the recurrence of depression. Neither did they report on the presence of depression or the need for treatment with antidepressants between the times of assessment. Furthermore, whether effective psychiatric treatment prior to surgery and prophylactic antidepressants (which are well-established methods of decreasing the risk of depression relapse according to the general psychiatric literature 10 ) change the outcomes in patients with severe depression at the time of surgery is not known. Whether preoperative treatment of these psychiatric disorders changes outcome in general is also not known and needs further careful study.
Three of the 12 patients in whom surgery was contraindicated were excluded from STN DBS because of cognitive impairment. Given the lack of guidelines and ambiguity in the literature as well as the lack of evidence concerning patients whose psychiatric symptoms had been adequately treated preoperatively, the remaining nine patients were considered appropriate for surgery following effective psychiatric treatment. Two patients with a history of attempted suicide were carefully evaluated and their attempts were considered to be a low risk.
Eight of 11 patients have since undergone surgery and have at least 3 months of available postoperative data. The remaining three patients have either recently undergone, or are awaiting, surgery. Postoperative data were obtained from an uncontrolled series and were based on a small cohort with varying diagnoses, and the follow up was of variable and limited duration. Furthermore, the data have not been analyzed with respect to electrode placement, degree or rate of change of medications, or psychosocial factors. The frequency of postoperative psychiatric outcomes among this series will also be elevated as these patients have been closely observed; a control group similarly followed up would be required to determine if the frequency is different from that in the general PD population undergoing STN DBS. Thus, the data cannot be considered indicative of the role of preoperative vulnerability in postoperative psychiatric outcomes and are too limited to be generalizable. Nevertheless, the preliminary data indicate that preoperative medication-induced mania, consistent with previous observations of hypomania, 9 may be associated with transient postoperative mania within the early postoperative period, which responds to the usual treatments. Effectively treated moderate to severe depression was associated with postoperative depression in one of four patients; postoperative depression was also responsive to treatment. A previous suicide attempt screened appropriately for degree of severity is not necessarily a contraindication for surgery. The postoperative psychiatric symptoms have all been transient and manageable. In addition to preoperative psychiatric intervention, these patients require close postoperative psychiatric follow up.
Conclusions
We reported the results of a systematic psychiatric assessment of lifetime and current psychiatric diagnoses in 40 consecutive patients with advanced PD who had presented for assessment for STN DBS surgery and highlighted the high burden of psychiatric disorders in this population. Notably, which preoperative symptoms improve either directly or indirectly due to STN stimulation or decreases in dopaminergic medications and which patients are at risk for decompensation and require preoperative psychiatric intervention is not yet known. Furthermore, there is insufficient evidence in the literature to determine whether the current presence or severity of preoperative psychiatric symptoms or a previous history of psychiatric disorders should be used as contraindications for surgery. Severe depression at the time of assessment for surgery should be considered as a relative contraindication pending the disorder's successful treatment. Note that psychiatric disorders, in contrast to cognitive deficits, are potentially reversible and treatable. We emphasize the need for large-scale prospective studies to investigate risk factors associated with postoperative psychiatric symptoms, for evidence-based guidelines for the treatment of patients with these symptoms, and for involvement of psychiatric personnel in the treatment of these patients.
